High-resolution contrast-enhanced MRI with three-dimensional fast spin echo improved the diagnostic performance for identifying pituitary microadenomas in Cushing’s syndrome - Report - MDSpire
Advertisement
High-resolution contrast-enhanced MRI with three-dimensional fast spin echo improved the diagnostic performance for identifying pituitary microadenomas in Cushing’s syndrome
Enhanced Diagnostic Accuracy for Pituitary Microadenomas in Cushing’s Syndrome Using 3D FSE MRI
Overview
This study demonstrates that high-resolution 3D fast spin echo (3D FSE) MRI significantly improves the detection of ACTH-secreting pituitary microadenomas in patients with Cushing’s syndrome compared to conventional and dynamic 2D FSE MRI. The 3D FSE sequence offers superior image quality and higher sensitivity, potentially increasing preoperative diagnostic accuracy and surgical remission rates.
Background
Cushing’s syndrome results from excessive glucocorticoid exposure and is commonly caused by ACTH-secreting pituitary microadenomas in Cushing’s disease. Accurate preoperative identification of these microadenomas is critical, as it substantially improves surgical outcomes. Conventional MRI techniques, including 2D fast spin echo (FSE) sequences, often miss small lesions due to limited resolution and slice thickness. Although dynamic contrast-enhanced MRI and 3D spoiled gradient recalled sequences have improved detection rates, a significant proportion of microadenomas remain undetected, necessitating improved imaging methods.
Data Highlights
Imaging Technique
Slice Thickness (mm)
Sensitivity for Microadenoma Detection
False Negative Rate
Image Quality Metrics
Conventional MRI (2D FSE)
2-3
~50%
Up to 50%
Lower overall quality and sharpness
Dynamic MRI (2D FSE)
2-3
66%
Increased false positives
Improved sensitivity but compromised specificity
High-Resolution MRI (3D SPGR)
1-1.2
Up to 80%
~20% missed lesions
Better resolution but still misses some lesions
High-Resolution MRI (3D FSE)
Not specified (superior to 3D SPGR)
Higher than 80%
Lower false negatives
Superior image quality with diminished artifacts
Key Findings
3D FSE MRI provides superior image quality and sharpness compared to conventional and dynamic 2D FSE MRI sequences.
3D FSE MRI significantly improves the sensitivity for detecting ACTH-secreting pituitary microadenomas in Cushing’s syndrome patients.
Conventional 2D FSE MRI has a high false negative rate, missing up to 50% of microadenomas.
Dynamic contrast-enhanced MRI increases sensitivity but also raises false positive rates.
3D SPGR sequences improve detection rates to about 80%, but 3D FSE sequences further reduce missed lesions.
The study supports the use of 3D FSE MRI as a reliable alternative for pituitary imaging with better diagnostic performance.
Clinical Implications
Incorporating high-resolution 3D FSE MRI into the preoperative imaging protocol for patients with suspected Cushing’s disease can enhance the detection of pituitary microadenomas, leading to improved surgical planning and higher remission rates. Radiologists and endocrinologists should consider 3D FSE sequences to reduce false negatives and optimize patient outcomes. This technique may also reduce the need for additional imaging or invasive diagnostic procedures.
Conclusion
High-resolution 3D FSE MRI markedly improves the identification of ACTH-secreting pituitary microadenomas in Cushing’s syndrome, outperforming conventional and dynamic 2D FSE MRI. Adoption of this imaging modality can enhance diagnostic accuracy and support better clinical management.
References
Endocrine Society Clinical Practice Guideline -- Diagnosis and Treatment of Cushing’s Syndrome
Sartoretti et al. 2020 -- 3D FSE Sequence for Pituitary Imaging
Previous Studies on 3D SPGR MRI Sensitivity -- 2011-2015
